Riggs Josh has filed 12 insider transactions across 1 company since January 2023.
Most recent transaction: a option exercise of 47170 shares of Insight Molecular Diagnostics Inc. ($IMDX) on March 26, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2026 | Insight Molecular Diagnostics Inc. | $IMDX | Riggs Josh | CEO and President | M | Common Stock | 47170 | $0.00 | 50,675.0000 | 32,033,000 | 1345.79% | 0.15% |
| March 26, 2026 | Insight Molecular Diagnostics Inc. | $IMDX | Riggs Josh | CEO and President | M | Restricted Stock Units | 47170 | $0.00 | 141,509.0000 | 32,033,000 | 25.00% | 0.15% |
| March 26, 2026 | Insight Molecular Diagnostics Inc. | $IMDX | Riggs Josh | CEO and President | F | Common Stock | 12310 | $4.11 | 38,365.0000 | 32,033,000 | 24.29% | 0.04% |
| Sept. 28, 2025 | Insight Molecular Diagnostics Inc. | $IMDX | Riggs Josh | CEO and President | A | Option to Purchase Common Stock | 400000 | $0.00 | 400,000.0000 | 13,071,000 | 9999.99% | 3.06% |
| March 26, 2025 | Insight Molecular Diagnostics Inc. | $IMDX | Riggs Josh | CEO and President | A | Restricted Stock Units | 188679 | $0.00 | 188,679.0000 | 13,071,000 | 9999.99% | 1.44% |
| May 20, 2024 | Insight Molecular Diagnostics Inc. | $IMDX | Riggs Josh | CEO and President | A | Option to Purchase Common Stock | 90000 | $0.00 | 90,000.0000 | 7,651,000 | 9999.99% | 1.18% |
| April 11, 2024 | Insight Molecular Diagnostics Inc. | $IMDX | Riggs Josh | CEO and President | P | Common Stock, no par value | 3390 | $2.95 | 3,505.0000 | 7,651,000 | 2947.83% | 0.04% |
| Aug. 15, 2023 | Insight Molecular Diagnostics Inc. | $IMDX | Riggs Josh | CEO and President | A | Option to Purchase Common Stock | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 9, 2023 | Insight Molecular Diagnostics Inc. | $IMDX | Riggs Josh | CEO and President | A | Option to Purchase Common Stock | 800000 | $0.00 | 800,000.0000 | 0 | 9999.99% | 0.00% |
| June 9, 2023 | Insight Molecular Diagnostics Inc. | $IMDX | Riggs Josh | CEO and President | A | Option to Purchase Common Stock | 350000 | $0.00 | 350,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2023 | Insight Molecular Diagnostics Inc. | $IMDX | Riggs Josh | CEO | A | Option to Purchase Common Stock | 116426 | $0.00 | 116,426.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2023 | Insight Molecular Diagnostics Inc. | $IMDX | Riggs Josh | Interim CEO | A | Option to Purchase Common Stock | 257485 | $0.00 | 257,485.0000 | 0 | 9999.99% | 0.00% |